Review




Structured Review

Pharmatech ube2m knockdown mice
<t>UBE2M</t> is upregulated in human psoriatic skin and IMQ-induced psoriasis-like dermatitis in mice (A) Western blot analysis of Nedd8 protein expression in healthy skin samples and psoriatic lesional skin samples ( n = 5 human per each group). High-molecular-weight NEDD8-protein conjugates were used as a readout of global neddylation. The band at ∼10 kDa corresponds to free NEDD8. GAPDH served as the loading control. (B) Western blot analysis and quantification of UBE2M protein expression in healthy skin samples (HD) and psoriatic lesional skin samples (PL, n = 5 human per each group). GAPDH was used as the loading control. (C) The expression of UBE2M in psoriatic lesions compared with healthy skin from GEO: GSE13355 . UBE2M is upregulated in psoriatic lesions. (D) mRNA expression level of UBE2M was quantified in HD and PL ( n = 5 human per each group) via quantitative PCR. β-actin served as the internal control. (E) Immunohistochemical detection of UBE2M expression in healthy and psoriatic lesional skin ( n = 5 human per each group). Enlarged images in the box were present on the side below. Scale bars, 100 μm. (F) A diagram of a psoriasis model in C57BL/6, prepared by IMQ. (G) mRNA expression level of UBE2M was quantified in VAS and IMQ group ( n = 4 mice per each group) via quantitative PCR. β-actin served as the internal control. (H) Immunohistochemical detection of UBE2M expression in the VAS and IMQ group ( n = 4 mice per each group). Enlarged images in the box were present on the side below. Scale bars, 100 μm. (I) Western blot analysis and quantification of UBE2M protein expression in the VAS group and IMQ group ( n = 4 mice per each group). GAPDH was employed as the loading control. (J) Western blot analysis of Nedd8 protein expression in the VAS and IMQ groups ( n = 4 mice per each group). High-molecular-weight NEDD8-protein conjugates were used as a readout of global neddylation. The band at ∼10 kDa corresponds to free NEDD8. GAPDH served as the loading control. (K) Western blot analysis and quantification of UBE2M protein expression in HaCaT cells treated with the indicated concentration. ( n = 3 biologically independent experiments). (L) Western blot analysis was performed to evaluate UBE2M protein levels in HaCaT cells exposed to IL-17A (25 ng/mL) for the specified durations, with GAPDH serving as the loading control. ( n = 3 biologically independent experiments). All data are expressed as mean ± SD. ∗ p < 0.05, ∗∗ p < 0.01, ∗∗∗∗ p < 0.0001 by unpaired Student’s t test (B, D, E, G, H, and I) or by one-way ANOVA with post hoc Tukey (K and L).
Ube2m Knockdown Mice, supplied by Pharmatech, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/ube2m knockdown mice/product/Pharmatech
Average 86 stars, based on 1 article reviews
ube2m knockdown mice - by Bioz Stars, 2026-06
86/100 stars

Images

1) Product Images from "UBE2M-mediated EGFR neddylation drives keratinocyte proliferation in psoriasis"

Article Title: UBE2M-mediated EGFR neddylation drives keratinocyte proliferation in psoriasis

Journal: iScience

doi: 10.1016/j.isci.2026.115784

UBE2M is upregulated in human psoriatic skin and IMQ-induced psoriasis-like dermatitis in mice (A) Western blot analysis of Nedd8 protein expression in healthy skin samples and psoriatic lesional skin samples ( n = 5 human per each group). High-molecular-weight NEDD8-protein conjugates were used as a readout of global neddylation. The band at ∼10 kDa corresponds to free NEDD8. GAPDH served as the loading control. (B) Western blot analysis and quantification of UBE2M protein expression in healthy skin samples (HD) and psoriatic lesional skin samples (PL, n = 5 human per each group). GAPDH was used as the loading control. (C) The expression of UBE2M in psoriatic lesions compared with healthy skin from GEO: GSE13355 . UBE2M is upregulated in psoriatic lesions. (D) mRNA expression level of UBE2M was quantified in HD and PL ( n = 5 human per each group) via quantitative PCR. β-actin served as the internal control. (E) Immunohistochemical detection of UBE2M expression in healthy and psoriatic lesional skin ( n = 5 human per each group). Enlarged images in the box were present on the side below. Scale bars, 100 μm. (F) A diagram of a psoriasis model in C57BL/6, prepared by IMQ. (G) mRNA expression level of UBE2M was quantified in VAS and IMQ group ( n = 4 mice per each group) via quantitative PCR. β-actin served as the internal control. (H) Immunohistochemical detection of UBE2M expression in the VAS and IMQ group ( n = 4 mice per each group). Enlarged images in the box were present on the side below. Scale bars, 100 μm. (I) Western blot analysis and quantification of UBE2M protein expression in the VAS group and IMQ group ( n = 4 mice per each group). GAPDH was employed as the loading control. (J) Western blot analysis of Nedd8 protein expression in the VAS and IMQ groups ( n = 4 mice per each group). High-molecular-weight NEDD8-protein conjugates were used as a readout of global neddylation. The band at ∼10 kDa corresponds to free NEDD8. GAPDH served as the loading control. (K) Western blot analysis and quantification of UBE2M protein expression in HaCaT cells treated with the indicated concentration. ( n = 3 biologically independent experiments). (L) Western blot analysis was performed to evaluate UBE2M protein levels in HaCaT cells exposed to IL-17A (25 ng/mL) for the specified durations, with GAPDH serving as the loading control. ( n = 3 biologically independent experiments). All data are expressed as mean ± SD. ∗ p < 0.05, ∗∗ p < 0.01, ∗∗∗∗ p < 0.0001 by unpaired Student’s t test (B, D, E, G, H, and I) or by one-way ANOVA with post hoc Tukey (K and L).
Figure Legend Snippet: UBE2M is upregulated in human psoriatic skin and IMQ-induced psoriasis-like dermatitis in mice (A) Western blot analysis of Nedd8 protein expression in healthy skin samples and psoriatic lesional skin samples ( n = 5 human per each group). High-molecular-weight NEDD8-protein conjugates were used as a readout of global neddylation. The band at ∼10 kDa corresponds to free NEDD8. GAPDH served as the loading control. (B) Western blot analysis and quantification of UBE2M protein expression in healthy skin samples (HD) and psoriatic lesional skin samples (PL, n = 5 human per each group). GAPDH was used as the loading control. (C) The expression of UBE2M in psoriatic lesions compared with healthy skin from GEO: GSE13355 . UBE2M is upregulated in psoriatic lesions. (D) mRNA expression level of UBE2M was quantified in HD and PL ( n = 5 human per each group) via quantitative PCR. β-actin served as the internal control. (E) Immunohistochemical detection of UBE2M expression in healthy and psoriatic lesional skin ( n = 5 human per each group). Enlarged images in the box were present on the side below. Scale bars, 100 μm. (F) A diagram of a psoriasis model in C57BL/6, prepared by IMQ. (G) mRNA expression level of UBE2M was quantified in VAS and IMQ group ( n = 4 mice per each group) via quantitative PCR. β-actin served as the internal control. (H) Immunohistochemical detection of UBE2M expression in the VAS and IMQ group ( n = 4 mice per each group). Enlarged images in the box were present on the side below. Scale bars, 100 μm. (I) Western blot analysis and quantification of UBE2M protein expression in the VAS group and IMQ group ( n = 4 mice per each group). GAPDH was employed as the loading control. (J) Western blot analysis of Nedd8 protein expression in the VAS and IMQ groups ( n = 4 mice per each group). High-molecular-weight NEDD8-protein conjugates were used as a readout of global neddylation. The band at ∼10 kDa corresponds to free NEDD8. GAPDH served as the loading control. (K) Western blot analysis and quantification of UBE2M protein expression in HaCaT cells treated with the indicated concentration. ( n = 3 biologically independent experiments). (L) Western blot analysis was performed to evaluate UBE2M protein levels in HaCaT cells exposed to IL-17A (25 ng/mL) for the specified durations, with GAPDH serving as the loading control. ( n = 3 biologically independent experiments). All data are expressed as mean ± SD. ∗ p < 0.05, ∗∗ p < 0.01, ∗∗∗∗ p < 0.0001 by unpaired Student’s t test (B, D, E, G, H, and I) or by one-way ANOVA with post hoc Tukey (K and L).

Techniques Used: Western Blot, Expressing, High Molecular Weight, Control, Real-time Polymerase Chain Reaction, Immunohistochemical staining, Concentration Assay

UBE2M regulates KC proliferation and migration (A) Western blot analysis was conducted to assess UBE2M expression in HaCaT cells treated with OE-Control or OE-UBE2M. GAPDH served as the loading control. Representative immunoblots from one of three independent experiments are shown ( n = 3 independent repeat experiments). (B) Western blot analysis was performed to evaluate UBE2M expression in HaCaT cells transfected with sh-NC or sh-UBE2M. Representative immunoblots from one of three independent experiments are shown ( n = 3 independent repeat experiments). (C–E) Cell proliferation in HaCaT, ker-CT, and NHEK cells with OE-UBE2M and sh-UBE2M expression was assessed using the CCK-8 assay. ( n = 3 biologically independent experiments). (F) Ki67 staining was performed to assess cell proliferation in NHEK cells with UBE2M overexpression and knockdown. Nuclei were visualized using DAPI staining (blue). The percentage of Ki67-positive cells was quantified. Scale bars, 50 μm. ( n = 3 biologically independent experiments). (G) EdU staining was used to evaluate cell proliferation in NHEK cells with UBE2M overexpression and knockdown. Nuclei were stained with DAPI (blue) for visualization. The proportion of EdU-positive cells was calculated. Scale bars, 50 μm ( n = 3 biologically independent experiments). (H) Representative image of a colony formation assay showing HaCaT cell growth after treatment with OE-UBE2M or sh-UBE2M. The number of colonies of each group was quantified. ( n = 3 biologically independent experiments). (I) Wound-healing assay to analyze the migration capability of HaCaT cells with OE-UBE2M and sh-UBE2M mutation expression. Cells were photographed every 24 h. The migration rates of each group were quantified. Scale bars, 500 μm ( n = 3 biologically independent experiments). (J) CCK-8 assay analysis of cell proliferation of HaCaT cells with IL-17 upon UBE2M knockdown. ( n = 3 biologically independent experiments). (K) CCK-8 assay analysis of cell proliferation of HaCaT cells with mln4924 upon UBE2M overexpression. ( n = 3 biologically independent experiments). All data are expressed as mean ± SD. ∗ p < 0.05, ∗∗ p < 0.01, ∗∗∗ p < 0.001, ∗∗∗∗ p < 0.0001 by unpaired Student’s t test (C, D, E, J, and K) or by one-way ANOVA with post hoc Tukey (F, G, H, and I).
Figure Legend Snippet: UBE2M regulates KC proliferation and migration (A) Western blot analysis was conducted to assess UBE2M expression in HaCaT cells treated with OE-Control or OE-UBE2M. GAPDH served as the loading control. Representative immunoblots from one of three independent experiments are shown ( n = 3 independent repeat experiments). (B) Western blot analysis was performed to evaluate UBE2M expression in HaCaT cells transfected with sh-NC or sh-UBE2M. Representative immunoblots from one of three independent experiments are shown ( n = 3 independent repeat experiments). (C–E) Cell proliferation in HaCaT, ker-CT, and NHEK cells with OE-UBE2M and sh-UBE2M expression was assessed using the CCK-8 assay. ( n = 3 biologically independent experiments). (F) Ki67 staining was performed to assess cell proliferation in NHEK cells with UBE2M overexpression and knockdown. Nuclei were visualized using DAPI staining (blue). The percentage of Ki67-positive cells was quantified. Scale bars, 50 μm. ( n = 3 biologically independent experiments). (G) EdU staining was used to evaluate cell proliferation in NHEK cells with UBE2M overexpression and knockdown. Nuclei were stained with DAPI (blue) for visualization. The proportion of EdU-positive cells was calculated. Scale bars, 50 μm ( n = 3 biologically independent experiments). (H) Representative image of a colony formation assay showing HaCaT cell growth after treatment with OE-UBE2M or sh-UBE2M. The number of colonies of each group was quantified. ( n = 3 biologically independent experiments). (I) Wound-healing assay to analyze the migration capability of HaCaT cells with OE-UBE2M and sh-UBE2M mutation expression. Cells were photographed every 24 h. The migration rates of each group were quantified. Scale bars, 500 μm ( n = 3 biologically independent experiments). (J) CCK-8 assay analysis of cell proliferation of HaCaT cells with IL-17 upon UBE2M knockdown. ( n = 3 biologically independent experiments). (K) CCK-8 assay analysis of cell proliferation of HaCaT cells with mln4924 upon UBE2M overexpression. ( n = 3 biologically independent experiments). All data are expressed as mean ± SD. ∗ p < 0.05, ∗∗ p < 0.01, ∗∗∗ p < 0.001, ∗∗∗∗ p < 0.0001 by unpaired Student’s t test (C, D, E, J, and K) or by one-way ANOVA with post hoc Tukey (F, G, H, and I).

Techniques Used: Migration, Western Blot, Expressing, Control, Transfection, CCK-8 Assay, Staining, Over Expression, Knockdown, Colony Assay, Wound Healing Assay, Mutagenesis

UBE2M knockdown inhibits the immunopathological changes and blocks psoriasis development in the IMQ-induced mouse model (A) mRNA expression level of UBE2M was quantified in WT and Ube2m +/− mice via quantitative PCR. ( n = 4 mice per each group). β-actin served as the internal control. (B) UBE2M expression in the skin of WT nd Ube2m +/− mice was detected by Western blot and quantification for the indicated bands. ( n = 4 mice per each group). GAPDH served as the loading control. (C) Representative photos of dorsal skin in WT and Ube2m +/− mice with IMQ and VAS treatments. Images from all biological replicates ( n = 4 mice per group) are provided in . (D) Representative photos of spleen in WT and Ube2m +/− mice with IMQ treatments ( n = 4 mice per each group). Mouse spleen index in WT and Ube2m +/− mice after IMQ treatment and quantification for the spleen index. Images from all biological replicates ( n = 4 mice per group) are provided in . (E) Scores of erythema, scaling, thickness, and cumulative scores of WT mice and Ube2m +/− mice after IMQ treatment. ( n = 4 mice per each group). (F) Histological staining of skin tissue with H&E from the back of WT and Ube2m +/− mice. Enlarged images in the box were present on the lower side. Scale bars, 100 μm ( n = 4 mice per each group). (G) Immunohistochemistry staining of IMQ or VAS-treated skin of WT and Ube2m +/− mice by Ki-67. The quantitative analysis of Ki-67 positive cell rates was detected by ImageJ. Scale bars, 100 μm ( n = 4 mice per each group). (H–K) Quantitative PCR analysis of mRNA level of the Il17a , Il23 , Tnfα , and MCP-1 genes in WT mice and Ube2m +/− mice after IMQ or VAS treatment. ( n = 4 mice per each group). β-actin served as the internal control. All data are expressed as mean ± SD. ns., not significant, ∗ p < 0.05, ∗∗ p < 0.01, ∗∗∗ p < 0.001, ∗∗∗∗ p < 0.0001 by unpaired Student’s t test (A, B, D, and E) or by one-way ANOVA with post hoc Tukey (F, G, H, I, J, and K).
Figure Legend Snippet: UBE2M knockdown inhibits the immunopathological changes and blocks psoriasis development in the IMQ-induced mouse model (A) mRNA expression level of UBE2M was quantified in WT and Ube2m +/− mice via quantitative PCR. ( n = 4 mice per each group). β-actin served as the internal control. (B) UBE2M expression in the skin of WT nd Ube2m +/− mice was detected by Western blot and quantification for the indicated bands. ( n = 4 mice per each group). GAPDH served as the loading control. (C) Representative photos of dorsal skin in WT and Ube2m +/− mice with IMQ and VAS treatments. Images from all biological replicates ( n = 4 mice per group) are provided in . (D) Representative photos of spleen in WT and Ube2m +/− mice with IMQ treatments ( n = 4 mice per each group). Mouse spleen index in WT and Ube2m +/− mice after IMQ treatment and quantification for the spleen index. Images from all biological replicates ( n = 4 mice per group) are provided in . (E) Scores of erythema, scaling, thickness, and cumulative scores of WT mice and Ube2m +/− mice after IMQ treatment. ( n = 4 mice per each group). (F) Histological staining of skin tissue with H&E from the back of WT and Ube2m +/− mice. Enlarged images in the box were present on the lower side. Scale bars, 100 μm ( n = 4 mice per each group). (G) Immunohistochemistry staining of IMQ or VAS-treated skin of WT and Ube2m +/− mice by Ki-67. The quantitative analysis of Ki-67 positive cell rates was detected by ImageJ. Scale bars, 100 μm ( n = 4 mice per each group). (H–K) Quantitative PCR analysis of mRNA level of the Il17a , Il23 , Tnfα , and MCP-1 genes in WT mice and Ube2m +/− mice after IMQ or VAS treatment. ( n = 4 mice per each group). β-actin served as the internal control. All data are expressed as mean ± SD. ns., not significant, ∗ p < 0.05, ∗∗ p < 0.01, ∗∗∗ p < 0.001, ∗∗∗∗ p < 0.0001 by unpaired Student’s t test (A, B, D, and E) or by one-way ANOVA with post hoc Tukey (F, G, H, I, J, and K).

Techniques Used: Knockdown, Expressing, Real-time Polymerase Chain Reaction, Control, Western Blot, Staining, Immunohistochemistry

UBE2M modulates the expression and activity of EGFR through direct interaction with EGFR (A) EGFR and p-EGFR were modified upon the overexpression of UBE2M in HaCaT cell lines detected by western blot, alongside statistical analysis of the indicated proteins. ( n = 3 biologically independent experiments). GAPDH served as the loading control. (B) Densitometric gray value analysis of the p-EGFR/EGFR ratio was performed using ImageJ software, with GAPDH serving as the loading control. ( n = 3 biologically independent experiments). (C) EGFR was modified upon the knockdown of UBE2M in HaCaT cell lines detected by western blot. ( n = 3 biologically independent experiments). GAPDH served as the loading control. (D) HaCaT cells were transfected with UBE2M or UBE2M siRNA and then treated in the presence of cycloheximide (2 μg/ml) for the indicated times at 37°C. Then, it was detected by western blot. ( n = 3 biologically independent experiments). (E) HA-tagged ubiquitin and Flag-tagged EGFR were co-expressed in cells with or without UBE2M. EGFR was immunoprecipitated with anti-Flag antibody, followed by immunoblotting with anti-ubiquitin antibody. UBE2M overexpression decreased EGFR ubiquitination. Input shows the expression of HA-Ub, Flag-EGFR, and UBE2M. Representative immunoblots from one of three independent experiments are shown ( n = 3 independent repeat experiments). (F) EGFR expression in the skin of WT and Ube2m +/− mice was evaluated by western blot, with GAPDH serving as the loading control and quantification for the indicated bands. ( n = 4 mice per each group). (G) Immunohistochemical staining of EGFR in dorsal skin from wild-type and Ube2m heterozygous mice treated with VAS or IMQ. Scale bars, 100 μm ( n = 4 mice per each group). (H) Ligand-induced dimerization assay of EGFR by western blot. GAPDH serves as the loading control. ( n = 3 biologically independent experiments). (I) Western blot analysis of the activation of EGFR and AKT in HaCaT cells in the presence or absence of sh-UBE2M with or without EGF (20 ng/ml) stimulation. Densitometric gray value quantification of p-EGFR/EGFR ratios was performed using ImageJ software, with GAPDH serving as the loading control. ( n = 3 biologically independent experiments). (J) Protein expression of EGFR was examined by immunofluorescence staining in HaCaT cells treated with UBE2M. Scale bars, 10 μm. Representative images from one of three independent experiments are shown. ( n = 3 independent repeat experiments). (K–L) The interaction of UBE2M and EGFR was detected by CoIP. HaCaT cells were transfected with Flag-EGFR and HA-UBE2M for 48 h, followed by anti-HA (K) or anti-Flag (L) immunoprecipitation. Representative immunoblots from one of three independent experiments are shown ( n = 3 independent repeat experiments). (M) Endogenous UBE2M in HaCaT cells was shown to interact with EGFR through co-immunoprecipitation using UBE2M antibody. Mouse IgG served as a control. Representative immunoblots from one of three independent experiments are shown ( n = 3 independent repeat experiments). (N) Co-immunoprecipitation with EGFR antibody demonstrated the interaction between endogenous EGFR and UBE2M in HaCaT cells. Mouse IgG was used as a control. Representative immunoblots from one of three independent experiments are shown ( n = 3 independent repeat experiments). (O) In mouse skin, endogenous UBE2M interacted with EGFR through co-immunoprecipitation using UBE2M antibody. Mouse IgG acted as a control. Representative immunoblots from one of three independent experiments are shown ( n = 3 independent repeat experiments). (P) Co-immunoprecipitation with EGFR antibody revealed the interaction between endogenous EGFR and UBE2M in mouse skin. Mouse IgG was utilized as a control. Representative immunoblots from one of three independent experiments are shown ( n = 3 independent repeat experiments). (Q) The proliferation of HaCaT cells after overexpression of UBE2M and stimulation or non-stimulation of AG1478 was analyzed by the CCK-8 method. ( n = 3 biologically independent experiments). All data are expressed as mean ± SD. ns., not significant, ∗ p < 0.05, ∗∗ p < 0.01, ∗∗∗ p < 0.001, ∗∗∗∗ p < 0.0001 by unpaired Student’s t test (A, B, D, F, and Q) or by one-way ANOVA with post hoc Tukey (C, G, H, and I).
Figure Legend Snippet: UBE2M modulates the expression and activity of EGFR through direct interaction with EGFR (A) EGFR and p-EGFR were modified upon the overexpression of UBE2M in HaCaT cell lines detected by western blot, alongside statistical analysis of the indicated proteins. ( n = 3 biologically independent experiments). GAPDH served as the loading control. (B) Densitometric gray value analysis of the p-EGFR/EGFR ratio was performed using ImageJ software, with GAPDH serving as the loading control. ( n = 3 biologically independent experiments). (C) EGFR was modified upon the knockdown of UBE2M in HaCaT cell lines detected by western blot. ( n = 3 biologically independent experiments). GAPDH served as the loading control. (D) HaCaT cells were transfected with UBE2M or UBE2M siRNA and then treated in the presence of cycloheximide (2 μg/ml) for the indicated times at 37°C. Then, it was detected by western blot. ( n = 3 biologically independent experiments). (E) HA-tagged ubiquitin and Flag-tagged EGFR were co-expressed in cells with or without UBE2M. EGFR was immunoprecipitated with anti-Flag antibody, followed by immunoblotting with anti-ubiquitin antibody. UBE2M overexpression decreased EGFR ubiquitination. Input shows the expression of HA-Ub, Flag-EGFR, and UBE2M. Representative immunoblots from one of three independent experiments are shown ( n = 3 independent repeat experiments). (F) EGFR expression in the skin of WT and Ube2m +/− mice was evaluated by western blot, with GAPDH serving as the loading control and quantification for the indicated bands. ( n = 4 mice per each group). (G) Immunohistochemical staining of EGFR in dorsal skin from wild-type and Ube2m heterozygous mice treated with VAS or IMQ. Scale bars, 100 μm ( n = 4 mice per each group). (H) Ligand-induced dimerization assay of EGFR by western blot. GAPDH serves as the loading control. ( n = 3 biologically independent experiments). (I) Western blot analysis of the activation of EGFR and AKT in HaCaT cells in the presence or absence of sh-UBE2M with or without EGF (20 ng/ml) stimulation. Densitometric gray value quantification of p-EGFR/EGFR ratios was performed using ImageJ software, with GAPDH serving as the loading control. ( n = 3 biologically independent experiments). (J) Protein expression of EGFR was examined by immunofluorescence staining in HaCaT cells treated with UBE2M. Scale bars, 10 μm. Representative images from one of three independent experiments are shown. ( n = 3 independent repeat experiments). (K–L) The interaction of UBE2M and EGFR was detected by CoIP. HaCaT cells were transfected with Flag-EGFR and HA-UBE2M for 48 h, followed by anti-HA (K) or anti-Flag (L) immunoprecipitation. Representative immunoblots from one of three independent experiments are shown ( n = 3 independent repeat experiments). (M) Endogenous UBE2M in HaCaT cells was shown to interact with EGFR through co-immunoprecipitation using UBE2M antibody. Mouse IgG served as a control. Representative immunoblots from one of three independent experiments are shown ( n = 3 independent repeat experiments). (N) Co-immunoprecipitation with EGFR antibody demonstrated the interaction between endogenous EGFR and UBE2M in HaCaT cells. Mouse IgG was used as a control. Representative immunoblots from one of three independent experiments are shown ( n = 3 independent repeat experiments). (O) In mouse skin, endogenous UBE2M interacted with EGFR through co-immunoprecipitation using UBE2M antibody. Mouse IgG acted as a control. Representative immunoblots from one of three independent experiments are shown ( n = 3 independent repeat experiments). (P) Co-immunoprecipitation with EGFR antibody revealed the interaction between endogenous EGFR and UBE2M in mouse skin. Mouse IgG was utilized as a control. Representative immunoblots from one of three independent experiments are shown ( n = 3 independent repeat experiments). (Q) The proliferation of HaCaT cells after overexpression of UBE2M and stimulation or non-stimulation of AG1478 was analyzed by the CCK-8 method. ( n = 3 biologically independent experiments). All data are expressed as mean ± SD. ns., not significant, ∗ p < 0.05, ∗∗ p < 0.01, ∗∗∗ p < 0.001, ∗∗∗∗ p < 0.0001 by unpaired Student’s t test (A, B, D, F, and Q) or by one-way ANOVA with post hoc Tukey (C, G, H, and I).

Techniques Used: Expressing, Activity Assay, Modification, Over Expression, Western Blot, Control, Software, Knockdown, Transfection, Ubiquitin Proteomics, Immunoprecipitation, Immunohistochemical staining, Staining, Activation Assay, Immunofluorescence, CCK-8 Assay

UBE2M Enhances EGFR Neddylation (A) The NAE inhibitor MLN4924 inhibited the increase in EGFR expression mediated by UBE2M in the HaCaT cell line. The cells were administered MLN4924 (0.3 μM, 12 h) before harvesting. GAPDH served as the loading control and quantification for the indicated bands. ( n = 3 biologically independent experiments). (B) Western blot analysis of EGFR expression in HaCaT cells treated with UBE2M or UBE2M-C111S. GAPDH served as the loading control and quantification for the indicated bands. ( n = 3 biologically independent experiments). (C) EGFR associates with NEDD8. HA-NEDD8 and Flag-EGFR were transfected into HaCaT cells and treated with 0.3 μM MLN4924 for 12 h. Cell lysis was followed by immunoprecipitation with a Flag antibody, followed by immunoblotting with the indicated antibodies. Representative immunoblots from one of three independent experiments are shown ( n = 3 independent repeat experiments). (D) Endogenous EGFR is associated with NEDD8 via co-immunoprecipitation with the EGFR antibody. Mouse IgG was utilized as a control. Representative immunoblots from one of three independent experiments are shown ( n = 3 independent repeat experiments). (E) The neddylation of EGFR is increased upon UBE2M overexpression in HaCaT cells, detected by immunoprecipitation with a Flag antibody. Representative immunoblots from one of three independent experiments are shown ( n = 3 independent repeat experiments). (F) The neddylation of EGFR is reduced upon UBE2M knockdown in HaCaT cells, detected by immunoprecipitation with a Flag antibody. Representative immunoblots from one of three independent experiments are shown ( n = 3 independent repeat experiments). (G) In HaCaT cells, endogenous EGFR was shown to interact with NEDD8 through co-immunoprecipitation using EGFR antibody following IL-17 stimulation. Representative immunoblots from one of three independent experiments are shown ( n = 3 independent repeat experiments). (H) In HaCaT cells, endogenous NEDD8 was found to associate with EGFR through co-immunoprecipitation with NEDD8 antibody after IL-17 stimulation. Representative immunoblots from one of three independent experiments are shown ( n = 3 independent repeat experiments). (I) In Ker-CT cells, endogenous EGFR interacted with NEDD8 via co-immunoprecipitation using EGFR antibody following IL-17 stimulation. Representative immunoblots from one of three independent experiments are shown ( n = 3 independent repeat experiments). (J) Likewise, endogenous NEDD8 in Ker-CT cells was associated with EGFR through co-immunoprecipitation with NEDD8 antibody after IL-17 stimulation. Representative immunoblots from one of three independent experiments are shown ( n = 3 independent repeat experiments). (K) Endogenous EGFR in NHEK cells was found to associate with NEDD8 via co-immunoprecipitation using EGFR antibody after IL-17 treatment. Representative immunoblots from one of three independent experiments are shown ( n = 3 independent repeat experiments). (L) In NHEK cells, endogenous NEDD8 interacted with EGFR through co-immunoprecipitation using NEDD8 antibody after IL-17 stimulation. Representative immunoblots from one of three independent experiments are shown ( n = 3 independent repeat experiments). All data are expressed as mean ± SD. ∗ p < 0.05, ∗∗ p < 0.01 by one-way ANOVA with post hoc Tukey (A and B).
Figure Legend Snippet: UBE2M Enhances EGFR Neddylation (A) The NAE inhibitor MLN4924 inhibited the increase in EGFR expression mediated by UBE2M in the HaCaT cell line. The cells were administered MLN4924 (0.3 μM, 12 h) before harvesting. GAPDH served as the loading control and quantification for the indicated bands. ( n = 3 biologically independent experiments). (B) Western blot analysis of EGFR expression in HaCaT cells treated with UBE2M or UBE2M-C111S. GAPDH served as the loading control and quantification for the indicated bands. ( n = 3 biologically independent experiments). (C) EGFR associates with NEDD8. HA-NEDD8 and Flag-EGFR were transfected into HaCaT cells and treated with 0.3 μM MLN4924 for 12 h. Cell lysis was followed by immunoprecipitation with a Flag antibody, followed by immunoblotting with the indicated antibodies. Representative immunoblots from one of three independent experiments are shown ( n = 3 independent repeat experiments). (D) Endogenous EGFR is associated with NEDD8 via co-immunoprecipitation with the EGFR antibody. Mouse IgG was utilized as a control. Representative immunoblots from one of three independent experiments are shown ( n = 3 independent repeat experiments). (E) The neddylation of EGFR is increased upon UBE2M overexpression in HaCaT cells, detected by immunoprecipitation with a Flag antibody. Representative immunoblots from one of three independent experiments are shown ( n = 3 independent repeat experiments). (F) The neddylation of EGFR is reduced upon UBE2M knockdown in HaCaT cells, detected by immunoprecipitation with a Flag antibody. Representative immunoblots from one of three independent experiments are shown ( n = 3 independent repeat experiments). (G) In HaCaT cells, endogenous EGFR was shown to interact with NEDD8 through co-immunoprecipitation using EGFR antibody following IL-17 stimulation. Representative immunoblots from one of three independent experiments are shown ( n = 3 independent repeat experiments). (H) In HaCaT cells, endogenous NEDD8 was found to associate with EGFR through co-immunoprecipitation with NEDD8 antibody after IL-17 stimulation. Representative immunoblots from one of three independent experiments are shown ( n = 3 independent repeat experiments). (I) In Ker-CT cells, endogenous EGFR interacted with NEDD8 via co-immunoprecipitation using EGFR antibody following IL-17 stimulation. Representative immunoblots from one of three independent experiments are shown ( n = 3 independent repeat experiments). (J) Likewise, endogenous NEDD8 in Ker-CT cells was associated with EGFR through co-immunoprecipitation with NEDD8 antibody after IL-17 stimulation. Representative immunoblots from one of three independent experiments are shown ( n = 3 independent repeat experiments). (K) Endogenous EGFR in NHEK cells was found to associate with NEDD8 via co-immunoprecipitation using EGFR antibody after IL-17 treatment. Representative immunoblots from one of three independent experiments are shown ( n = 3 independent repeat experiments). (L) In NHEK cells, endogenous NEDD8 interacted with EGFR through co-immunoprecipitation using NEDD8 antibody after IL-17 stimulation. Representative immunoblots from one of three independent experiments are shown ( n = 3 independent repeat experiments). All data are expressed as mean ± SD. ∗ p < 0.05, ∗∗ p < 0.01 by one-way ANOVA with post hoc Tukey (A and B).

Techniques Used: Expressing, Control, Western Blot, Transfection, Lysis, Immunoprecipitation, Over Expression, Knockdown

CUL4A-RBX1 and CUL4B-RBX1 act as E3 ligases for EGFR neddylation (A and B) The interaction of RBX1 and EGFR was detected by CoIP. HaCaT cells were transfected with Flag-EGFR and HA-RBX1 for 48 h, followed by anti-Flag (A) or anti-HA (B) immunoprecipitation. Representative immunoblots from one of three independent experiments are shown ( n = 3 independent repeat experiments). (C) The interaction of EGFR and NEDD8 with and without RBX1 knockdown using siRNA. Anti-Flag immunoprecipitation was employed as indicated. Representative immunoblots from one of three independent experiments are shown ( n = 3 independent repeat experiments). (D) The neddylation of EGFR under various cullins knockdown conditions was detected by immunoprecipitation with a Flag antibody. Representative immunoblots from one of three independent experiments are shown ( n = 3 independent repeat experiments). (E and F) The interaction of EGFR and CUL4A was detected by CoIP. HaCaT cells were transfected with Flag-EGFR and MYC-CUL4A for 48 h, followed by anti-Flag (E) or anti-MYC (F) immunoprecipitation. Representative immunoblots from one of three independent experiments are shown ( n = 3 independent repeat experiments). (G and H) The interaction of EGFR and CUL4B was detected by CoIP. HaCaT cells were transfected with Flag-EGFR and HA-CUL4B for 48 h, followed by anti-Flag (G) or anti-HA (H) immunoprecipitation. Representative immunoblots from one of three independent experiments are shown ( n = 3 independent repeat experiments). (I and J) The physical interaction of NEDD8 and Flag-EGFR in HaCaT cells with and without CUL4A (I) or CUL4B (J) overexpression. Cell lysates were immunoprecipitated using Flag antibodies. Representative immunoblots from one of three independent experiments are shown ( n = 3 independent repeat experiments). (K) The physical interaction of CUL4A and CUL4B with endogenous EGFR in HaCaT cells with and without UBE2M overexpression. Cell lysates were immunoprecipitated with IgG or EGFR antibodies. Representative immunoblots from one of three independent experiments are shown ( n = 3 independent repeat experiments). (L) A diagrammatic summary of how UBE2M promotes the progression of psoriasis by enhancing EGFR neddylation and stability.
Figure Legend Snippet: CUL4A-RBX1 and CUL4B-RBX1 act as E3 ligases for EGFR neddylation (A and B) The interaction of RBX1 and EGFR was detected by CoIP. HaCaT cells were transfected with Flag-EGFR and HA-RBX1 for 48 h, followed by anti-Flag (A) or anti-HA (B) immunoprecipitation. Representative immunoblots from one of three independent experiments are shown ( n = 3 independent repeat experiments). (C) The interaction of EGFR and NEDD8 with and without RBX1 knockdown using siRNA. Anti-Flag immunoprecipitation was employed as indicated. Representative immunoblots from one of three independent experiments are shown ( n = 3 independent repeat experiments). (D) The neddylation of EGFR under various cullins knockdown conditions was detected by immunoprecipitation with a Flag antibody. Representative immunoblots from one of three independent experiments are shown ( n = 3 independent repeat experiments). (E and F) The interaction of EGFR and CUL4A was detected by CoIP. HaCaT cells were transfected with Flag-EGFR and MYC-CUL4A for 48 h, followed by anti-Flag (E) or anti-MYC (F) immunoprecipitation. Representative immunoblots from one of three independent experiments are shown ( n = 3 independent repeat experiments). (G and H) The interaction of EGFR and CUL4B was detected by CoIP. HaCaT cells were transfected with Flag-EGFR and HA-CUL4B for 48 h, followed by anti-Flag (G) or anti-HA (H) immunoprecipitation. Representative immunoblots from one of three independent experiments are shown ( n = 3 independent repeat experiments). (I and J) The physical interaction of NEDD8 and Flag-EGFR in HaCaT cells with and without CUL4A (I) or CUL4B (J) overexpression. Cell lysates were immunoprecipitated using Flag antibodies. Representative immunoblots from one of three independent experiments are shown ( n = 3 independent repeat experiments). (K) The physical interaction of CUL4A and CUL4B with endogenous EGFR in HaCaT cells with and without UBE2M overexpression. Cell lysates were immunoprecipitated with IgG or EGFR antibodies. Representative immunoblots from one of three independent experiments are shown ( n = 3 independent repeat experiments). (L) A diagrammatic summary of how UBE2M promotes the progression of psoriasis by enhancing EGFR neddylation and stability.

Techniques Used: Transfection, Immunoprecipitation, Western Blot, Knockdown, Over Expression



Similar Products

86
Pharmatech ube2m knockdown mice
<t>UBE2M</t> is upregulated in human psoriatic skin and IMQ-induced psoriasis-like dermatitis in mice (A) Western blot analysis of Nedd8 protein expression in healthy skin samples and psoriatic lesional skin samples ( n = 5 human per each group). High-molecular-weight NEDD8-protein conjugates were used as a readout of global neddylation. The band at ∼10 kDa corresponds to free NEDD8. GAPDH served as the loading control. (B) Western blot analysis and quantification of UBE2M protein expression in healthy skin samples (HD) and psoriatic lesional skin samples (PL, n = 5 human per each group). GAPDH was used as the loading control. (C) The expression of UBE2M in psoriatic lesions compared with healthy skin from GEO: GSE13355 . UBE2M is upregulated in psoriatic lesions. (D) mRNA expression level of UBE2M was quantified in HD and PL ( n = 5 human per each group) via quantitative PCR. β-actin served as the internal control. (E) Immunohistochemical detection of UBE2M expression in healthy and psoriatic lesional skin ( n = 5 human per each group). Enlarged images in the box were present on the side below. Scale bars, 100 μm. (F) A diagram of a psoriasis model in C57BL/6, prepared by IMQ. (G) mRNA expression level of UBE2M was quantified in VAS and IMQ group ( n = 4 mice per each group) via quantitative PCR. β-actin served as the internal control. (H) Immunohistochemical detection of UBE2M expression in the VAS and IMQ group ( n = 4 mice per each group). Enlarged images in the box were present on the side below. Scale bars, 100 μm. (I) Western blot analysis and quantification of UBE2M protein expression in the VAS group and IMQ group ( n = 4 mice per each group). GAPDH was employed as the loading control. (J) Western blot analysis of Nedd8 protein expression in the VAS and IMQ groups ( n = 4 mice per each group). High-molecular-weight NEDD8-protein conjugates were used as a readout of global neddylation. The band at ∼10 kDa corresponds to free NEDD8. GAPDH served as the loading control. (K) Western blot analysis and quantification of UBE2M protein expression in HaCaT cells treated with the indicated concentration. ( n = 3 biologically independent experiments). (L) Western blot analysis was performed to evaluate UBE2M protein levels in HaCaT cells exposed to IL-17A (25 ng/mL) for the specified durations, with GAPDH serving as the loading control. ( n = 3 biologically independent experiments). All data are expressed as mean ± SD. ∗ p < 0.05, ∗∗ p < 0.01, ∗∗∗∗ p < 0.0001 by unpaired Student’s t test (B, D, E, G, H, and I) or by one-way ANOVA with post hoc Tukey (K and L).
Ube2m Knockdown Mice, supplied by Pharmatech, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/ube2m knockdown mice/product/Pharmatech
Average 86 stars, based on 1 article reviews
ube2m knockdown mice - by Bioz Stars, 2026-06
86/100 stars
  Buy from Supplier

Image Search Results


UBE2M is upregulated in human psoriatic skin and IMQ-induced psoriasis-like dermatitis in mice (A) Western blot analysis of Nedd8 protein expression in healthy skin samples and psoriatic lesional skin samples ( n = 5 human per each group). High-molecular-weight NEDD8-protein conjugates were used as a readout of global neddylation. The band at ∼10 kDa corresponds to free NEDD8. GAPDH served as the loading control. (B) Western blot analysis and quantification of UBE2M protein expression in healthy skin samples (HD) and psoriatic lesional skin samples (PL, n = 5 human per each group). GAPDH was used as the loading control. (C) The expression of UBE2M in psoriatic lesions compared with healthy skin from GEO: GSE13355 . UBE2M is upregulated in psoriatic lesions. (D) mRNA expression level of UBE2M was quantified in HD and PL ( n = 5 human per each group) via quantitative PCR. β-actin served as the internal control. (E) Immunohistochemical detection of UBE2M expression in healthy and psoriatic lesional skin ( n = 5 human per each group). Enlarged images in the box were present on the side below. Scale bars, 100 μm. (F) A diagram of a psoriasis model in C57BL/6, prepared by IMQ. (G) mRNA expression level of UBE2M was quantified in VAS and IMQ group ( n = 4 mice per each group) via quantitative PCR. β-actin served as the internal control. (H) Immunohistochemical detection of UBE2M expression in the VAS and IMQ group ( n = 4 mice per each group). Enlarged images in the box were present on the side below. Scale bars, 100 μm. (I) Western blot analysis and quantification of UBE2M protein expression in the VAS group and IMQ group ( n = 4 mice per each group). GAPDH was employed as the loading control. (J) Western blot analysis of Nedd8 protein expression in the VAS and IMQ groups ( n = 4 mice per each group). High-molecular-weight NEDD8-protein conjugates were used as a readout of global neddylation. The band at ∼10 kDa corresponds to free NEDD8. GAPDH served as the loading control. (K) Western blot analysis and quantification of UBE2M protein expression in HaCaT cells treated with the indicated concentration. ( n = 3 biologically independent experiments). (L) Western blot analysis was performed to evaluate UBE2M protein levels in HaCaT cells exposed to IL-17A (25 ng/mL) for the specified durations, with GAPDH serving as the loading control. ( n = 3 biologically independent experiments). All data are expressed as mean ± SD. ∗ p < 0.05, ∗∗ p < 0.01, ∗∗∗∗ p < 0.0001 by unpaired Student’s t test (B, D, E, G, H, and I) or by one-way ANOVA with post hoc Tukey (K and L).

Journal: iScience

Article Title: UBE2M-mediated EGFR neddylation drives keratinocyte proliferation in psoriasis

doi: 10.1016/j.isci.2026.115784

Figure Lengend Snippet: UBE2M is upregulated in human psoriatic skin and IMQ-induced psoriasis-like dermatitis in mice (A) Western blot analysis of Nedd8 protein expression in healthy skin samples and psoriatic lesional skin samples ( n = 5 human per each group). High-molecular-weight NEDD8-protein conjugates were used as a readout of global neddylation. The band at ∼10 kDa corresponds to free NEDD8. GAPDH served as the loading control. (B) Western blot analysis and quantification of UBE2M protein expression in healthy skin samples (HD) and psoriatic lesional skin samples (PL, n = 5 human per each group). GAPDH was used as the loading control. (C) The expression of UBE2M in psoriatic lesions compared with healthy skin from GEO: GSE13355 . UBE2M is upregulated in psoriatic lesions. (D) mRNA expression level of UBE2M was quantified in HD and PL ( n = 5 human per each group) via quantitative PCR. β-actin served as the internal control. (E) Immunohistochemical detection of UBE2M expression in healthy and psoriatic lesional skin ( n = 5 human per each group). Enlarged images in the box were present on the side below. Scale bars, 100 μm. (F) A diagram of a psoriasis model in C57BL/6, prepared by IMQ. (G) mRNA expression level of UBE2M was quantified in VAS and IMQ group ( n = 4 mice per each group) via quantitative PCR. β-actin served as the internal control. (H) Immunohistochemical detection of UBE2M expression in the VAS and IMQ group ( n = 4 mice per each group). Enlarged images in the box were present on the side below. Scale bars, 100 μm. (I) Western blot analysis and quantification of UBE2M protein expression in the VAS group and IMQ group ( n = 4 mice per each group). GAPDH was employed as the loading control. (J) Western blot analysis of Nedd8 protein expression in the VAS and IMQ groups ( n = 4 mice per each group). High-molecular-weight NEDD8-protein conjugates were used as a readout of global neddylation. The band at ∼10 kDa corresponds to free NEDD8. GAPDH served as the loading control. (K) Western blot analysis and quantification of UBE2M protein expression in HaCaT cells treated with the indicated concentration. ( n = 3 biologically independent experiments). (L) Western blot analysis was performed to evaluate UBE2M protein levels in HaCaT cells exposed to IL-17A (25 ng/mL) for the specified durations, with GAPDH serving as the loading control. ( n = 3 biologically independent experiments). All data are expressed as mean ± SD. ∗ p < 0.05, ∗∗ p < 0.01, ∗∗∗∗ p < 0.0001 by unpaired Student’s t test (B, D, E, G, H, and I) or by one-way ANOVA with post hoc Tukey (K and L).

Article Snippet: Ube2m -knockdown mice , Gem Pharmatech , T003161.

Techniques: Western Blot, Expressing, High Molecular Weight, Control, Real-time Polymerase Chain Reaction, Immunohistochemical staining, Concentration Assay

UBE2M regulates KC proliferation and migration (A) Western blot analysis was conducted to assess UBE2M expression in HaCaT cells treated with OE-Control or OE-UBE2M. GAPDH served as the loading control. Representative immunoblots from one of three independent experiments are shown ( n = 3 independent repeat experiments). (B) Western blot analysis was performed to evaluate UBE2M expression in HaCaT cells transfected with sh-NC or sh-UBE2M. Representative immunoblots from one of three independent experiments are shown ( n = 3 independent repeat experiments). (C–E) Cell proliferation in HaCaT, ker-CT, and NHEK cells with OE-UBE2M and sh-UBE2M expression was assessed using the CCK-8 assay. ( n = 3 biologically independent experiments). (F) Ki67 staining was performed to assess cell proliferation in NHEK cells with UBE2M overexpression and knockdown. Nuclei were visualized using DAPI staining (blue). The percentage of Ki67-positive cells was quantified. Scale bars, 50 μm. ( n = 3 biologically independent experiments). (G) EdU staining was used to evaluate cell proliferation in NHEK cells with UBE2M overexpression and knockdown. Nuclei were stained with DAPI (blue) for visualization. The proportion of EdU-positive cells was calculated. Scale bars, 50 μm ( n = 3 biologically independent experiments). (H) Representative image of a colony formation assay showing HaCaT cell growth after treatment with OE-UBE2M or sh-UBE2M. The number of colonies of each group was quantified. ( n = 3 biologically independent experiments). (I) Wound-healing assay to analyze the migration capability of HaCaT cells with OE-UBE2M and sh-UBE2M mutation expression. Cells were photographed every 24 h. The migration rates of each group were quantified. Scale bars, 500 μm ( n = 3 biologically independent experiments). (J) CCK-8 assay analysis of cell proliferation of HaCaT cells with IL-17 upon UBE2M knockdown. ( n = 3 biologically independent experiments). (K) CCK-8 assay analysis of cell proliferation of HaCaT cells with mln4924 upon UBE2M overexpression. ( n = 3 biologically independent experiments). All data are expressed as mean ± SD. ∗ p < 0.05, ∗∗ p < 0.01, ∗∗∗ p < 0.001, ∗∗∗∗ p < 0.0001 by unpaired Student’s t test (C, D, E, J, and K) or by one-way ANOVA with post hoc Tukey (F, G, H, and I).

Journal: iScience

Article Title: UBE2M-mediated EGFR neddylation drives keratinocyte proliferation in psoriasis

doi: 10.1016/j.isci.2026.115784

Figure Lengend Snippet: UBE2M regulates KC proliferation and migration (A) Western blot analysis was conducted to assess UBE2M expression in HaCaT cells treated with OE-Control or OE-UBE2M. GAPDH served as the loading control. Representative immunoblots from one of three independent experiments are shown ( n = 3 independent repeat experiments). (B) Western blot analysis was performed to evaluate UBE2M expression in HaCaT cells transfected with sh-NC or sh-UBE2M. Representative immunoblots from one of three independent experiments are shown ( n = 3 independent repeat experiments). (C–E) Cell proliferation in HaCaT, ker-CT, and NHEK cells with OE-UBE2M and sh-UBE2M expression was assessed using the CCK-8 assay. ( n = 3 biologically independent experiments). (F) Ki67 staining was performed to assess cell proliferation in NHEK cells with UBE2M overexpression and knockdown. Nuclei were visualized using DAPI staining (blue). The percentage of Ki67-positive cells was quantified. Scale bars, 50 μm. ( n = 3 biologically independent experiments). (G) EdU staining was used to evaluate cell proliferation in NHEK cells with UBE2M overexpression and knockdown. Nuclei were stained with DAPI (blue) for visualization. The proportion of EdU-positive cells was calculated. Scale bars, 50 μm ( n = 3 biologically independent experiments). (H) Representative image of a colony formation assay showing HaCaT cell growth after treatment with OE-UBE2M or sh-UBE2M. The number of colonies of each group was quantified. ( n = 3 biologically independent experiments). (I) Wound-healing assay to analyze the migration capability of HaCaT cells with OE-UBE2M and sh-UBE2M mutation expression. Cells were photographed every 24 h. The migration rates of each group were quantified. Scale bars, 500 μm ( n = 3 biologically independent experiments). (J) CCK-8 assay analysis of cell proliferation of HaCaT cells with IL-17 upon UBE2M knockdown. ( n = 3 biologically independent experiments). (K) CCK-8 assay analysis of cell proliferation of HaCaT cells with mln4924 upon UBE2M overexpression. ( n = 3 biologically independent experiments). All data are expressed as mean ± SD. ∗ p < 0.05, ∗∗ p < 0.01, ∗∗∗ p < 0.001, ∗∗∗∗ p < 0.0001 by unpaired Student’s t test (C, D, E, J, and K) or by one-way ANOVA with post hoc Tukey (F, G, H, and I).

Article Snippet: Ube2m -knockdown mice , Gem Pharmatech , T003161.

Techniques: Migration, Western Blot, Expressing, Control, Transfection, CCK-8 Assay, Staining, Over Expression, Knockdown, Colony Assay, Wound Healing Assay, Mutagenesis

UBE2M knockdown inhibits the immunopathological changes and blocks psoriasis development in the IMQ-induced mouse model (A) mRNA expression level of UBE2M was quantified in WT and Ube2m +/− mice via quantitative PCR. ( n = 4 mice per each group). β-actin served as the internal control. (B) UBE2M expression in the skin of WT nd Ube2m +/− mice was detected by Western blot and quantification for the indicated bands. ( n = 4 mice per each group). GAPDH served as the loading control. (C) Representative photos of dorsal skin in WT and Ube2m +/− mice with IMQ and VAS treatments. Images from all biological replicates ( n = 4 mice per group) are provided in . (D) Representative photos of spleen in WT and Ube2m +/− mice with IMQ treatments ( n = 4 mice per each group). Mouse spleen index in WT and Ube2m +/− mice after IMQ treatment and quantification for the spleen index. Images from all biological replicates ( n = 4 mice per group) are provided in . (E) Scores of erythema, scaling, thickness, and cumulative scores of WT mice and Ube2m +/− mice after IMQ treatment. ( n = 4 mice per each group). (F) Histological staining of skin tissue with H&E from the back of WT and Ube2m +/− mice. Enlarged images in the box were present on the lower side. Scale bars, 100 μm ( n = 4 mice per each group). (G) Immunohistochemistry staining of IMQ or VAS-treated skin of WT and Ube2m +/− mice by Ki-67. The quantitative analysis of Ki-67 positive cell rates was detected by ImageJ. Scale bars, 100 μm ( n = 4 mice per each group). (H–K) Quantitative PCR analysis of mRNA level of the Il17a , Il23 , Tnfα , and MCP-1 genes in WT mice and Ube2m +/− mice after IMQ or VAS treatment. ( n = 4 mice per each group). β-actin served as the internal control. All data are expressed as mean ± SD. ns., not significant, ∗ p < 0.05, ∗∗ p < 0.01, ∗∗∗ p < 0.001, ∗∗∗∗ p < 0.0001 by unpaired Student’s t test (A, B, D, and E) or by one-way ANOVA with post hoc Tukey (F, G, H, I, J, and K).

Journal: iScience

Article Title: UBE2M-mediated EGFR neddylation drives keratinocyte proliferation in psoriasis

doi: 10.1016/j.isci.2026.115784

Figure Lengend Snippet: UBE2M knockdown inhibits the immunopathological changes and blocks psoriasis development in the IMQ-induced mouse model (A) mRNA expression level of UBE2M was quantified in WT and Ube2m +/− mice via quantitative PCR. ( n = 4 mice per each group). β-actin served as the internal control. (B) UBE2M expression in the skin of WT nd Ube2m +/− mice was detected by Western blot and quantification for the indicated bands. ( n = 4 mice per each group). GAPDH served as the loading control. (C) Representative photos of dorsal skin in WT and Ube2m +/− mice with IMQ and VAS treatments. Images from all biological replicates ( n = 4 mice per group) are provided in . (D) Representative photos of spleen in WT and Ube2m +/− mice with IMQ treatments ( n = 4 mice per each group). Mouse spleen index in WT and Ube2m +/− mice after IMQ treatment and quantification for the spleen index. Images from all biological replicates ( n = 4 mice per group) are provided in . (E) Scores of erythema, scaling, thickness, and cumulative scores of WT mice and Ube2m +/− mice after IMQ treatment. ( n = 4 mice per each group). (F) Histological staining of skin tissue with H&E from the back of WT and Ube2m +/− mice. Enlarged images in the box were present on the lower side. Scale bars, 100 μm ( n = 4 mice per each group). (G) Immunohistochemistry staining of IMQ or VAS-treated skin of WT and Ube2m +/− mice by Ki-67. The quantitative analysis of Ki-67 positive cell rates was detected by ImageJ. Scale bars, 100 μm ( n = 4 mice per each group). (H–K) Quantitative PCR analysis of mRNA level of the Il17a , Il23 , Tnfα , and MCP-1 genes in WT mice and Ube2m +/− mice after IMQ or VAS treatment. ( n = 4 mice per each group). β-actin served as the internal control. All data are expressed as mean ± SD. ns., not significant, ∗ p < 0.05, ∗∗ p < 0.01, ∗∗∗ p < 0.001, ∗∗∗∗ p < 0.0001 by unpaired Student’s t test (A, B, D, and E) or by one-way ANOVA with post hoc Tukey (F, G, H, I, J, and K).

Article Snippet: Ube2m -knockdown mice , Gem Pharmatech , T003161.

Techniques: Knockdown, Expressing, Real-time Polymerase Chain Reaction, Control, Western Blot, Staining, Immunohistochemistry

UBE2M modulates the expression and activity of EGFR through direct interaction with EGFR (A) EGFR and p-EGFR were modified upon the overexpression of UBE2M in HaCaT cell lines detected by western blot, alongside statistical analysis of the indicated proteins. ( n = 3 biologically independent experiments). GAPDH served as the loading control. (B) Densitometric gray value analysis of the p-EGFR/EGFR ratio was performed using ImageJ software, with GAPDH serving as the loading control. ( n = 3 biologically independent experiments). (C) EGFR was modified upon the knockdown of UBE2M in HaCaT cell lines detected by western blot. ( n = 3 biologically independent experiments). GAPDH served as the loading control. (D) HaCaT cells were transfected with UBE2M or UBE2M siRNA and then treated in the presence of cycloheximide (2 μg/ml) for the indicated times at 37°C. Then, it was detected by western blot. ( n = 3 biologically independent experiments). (E) HA-tagged ubiquitin and Flag-tagged EGFR were co-expressed in cells with or without UBE2M. EGFR was immunoprecipitated with anti-Flag antibody, followed by immunoblotting with anti-ubiquitin antibody. UBE2M overexpression decreased EGFR ubiquitination. Input shows the expression of HA-Ub, Flag-EGFR, and UBE2M. Representative immunoblots from one of three independent experiments are shown ( n = 3 independent repeat experiments). (F) EGFR expression in the skin of WT and Ube2m +/− mice was evaluated by western blot, with GAPDH serving as the loading control and quantification for the indicated bands. ( n = 4 mice per each group). (G) Immunohistochemical staining of EGFR in dorsal skin from wild-type and Ube2m heterozygous mice treated with VAS or IMQ. Scale bars, 100 μm ( n = 4 mice per each group). (H) Ligand-induced dimerization assay of EGFR by western blot. GAPDH serves as the loading control. ( n = 3 biologically independent experiments). (I) Western blot analysis of the activation of EGFR and AKT in HaCaT cells in the presence or absence of sh-UBE2M with or without EGF (20 ng/ml) stimulation. Densitometric gray value quantification of p-EGFR/EGFR ratios was performed using ImageJ software, with GAPDH serving as the loading control. ( n = 3 biologically independent experiments). (J) Protein expression of EGFR was examined by immunofluorescence staining in HaCaT cells treated with UBE2M. Scale bars, 10 μm. Representative images from one of three independent experiments are shown. ( n = 3 independent repeat experiments). (K–L) The interaction of UBE2M and EGFR was detected by CoIP. HaCaT cells were transfected with Flag-EGFR and HA-UBE2M for 48 h, followed by anti-HA (K) or anti-Flag (L) immunoprecipitation. Representative immunoblots from one of three independent experiments are shown ( n = 3 independent repeat experiments). (M) Endogenous UBE2M in HaCaT cells was shown to interact with EGFR through co-immunoprecipitation using UBE2M antibody. Mouse IgG served as a control. Representative immunoblots from one of three independent experiments are shown ( n = 3 independent repeat experiments). (N) Co-immunoprecipitation with EGFR antibody demonstrated the interaction between endogenous EGFR and UBE2M in HaCaT cells. Mouse IgG was used as a control. Representative immunoblots from one of three independent experiments are shown ( n = 3 independent repeat experiments). (O) In mouse skin, endogenous UBE2M interacted with EGFR through co-immunoprecipitation using UBE2M antibody. Mouse IgG acted as a control. Representative immunoblots from one of three independent experiments are shown ( n = 3 independent repeat experiments). (P) Co-immunoprecipitation with EGFR antibody revealed the interaction between endogenous EGFR and UBE2M in mouse skin. Mouse IgG was utilized as a control. Representative immunoblots from one of three independent experiments are shown ( n = 3 independent repeat experiments). (Q) The proliferation of HaCaT cells after overexpression of UBE2M and stimulation or non-stimulation of AG1478 was analyzed by the CCK-8 method. ( n = 3 biologically independent experiments). All data are expressed as mean ± SD. ns., not significant, ∗ p < 0.05, ∗∗ p < 0.01, ∗∗∗ p < 0.001, ∗∗∗∗ p < 0.0001 by unpaired Student’s t test (A, B, D, F, and Q) or by one-way ANOVA with post hoc Tukey (C, G, H, and I).

Journal: iScience

Article Title: UBE2M-mediated EGFR neddylation drives keratinocyte proliferation in psoriasis

doi: 10.1016/j.isci.2026.115784

Figure Lengend Snippet: UBE2M modulates the expression and activity of EGFR through direct interaction with EGFR (A) EGFR and p-EGFR were modified upon the overexpression of UBE2M in HaCaT cell lines detected by western blot, alongside statistical analysis of the indicated proteins. ( n = 3 biologically independent experiments). GAPDH served as the loading control. (B) Densitometric gray value analysis of the p-EGFR/EGFR ratio was performed using ImageJ software, with GAPDH serving as the loading control. ( n = 3 biologically independent experiments). (C) EGFR was modified upon the knockdown of UBE2M in HaCaT cell lines detected by western blot. ( n = 3 biologically independent experiments). GAPDH served as the loading control. (D) HaCaT cells were transfected with UBE2M or UBE2M siRNA and then treated in the presence of cycloheximide (2 μg/ml) for the indicated times at 37°C. Then, it was detected by western blot. ( n = 3 biologically independent experiments). (E) HA-tagged ubiquitin and Flag-tagged EGFR were co-expressed in cells with or without UBE2M. EGFR was immunoprecipitated with anti-Flag antibody, followed by immunoblotting with anti-ubiquitin antibody. UBE2M overexpression decreased EGFR ubiquitination. Input shows the expression of HA-Ub, Flag-EGFR, and UBE2M. Representative immunoblots from one of three independent experiments are shown ( n = 3 independent repeat experiments). (F) EGFR expression in the skin of WT and Ube2m +/− mice was evaluated by western blot, with GAPDH serving as the loading control and quantification for the indicated bands. ( n = 4 mice per each group). (G) Immunohistochemical staining of EGFR in dorsal skin from wild-type and Ube2m heterozygous mice treated with VAS or IMQ. Scale bars, 100 μm ( n = 4 mice per each group). (H) Ligand-induced dimerization assay of EGFR by western blot. GAPDH serves as the loading control. ( n = 3 biologically independent experiments). (I) Western blot analysis of the activation of EGFR and AKT in HaCaT cells in the presence or absence of sh-UBE2M with or without EGF (20 ng/ml) stimulation. Densitometric gray value quantification of p-EGFR/EGFR ratios was performed using ImageJ software, with GAPDH serving as the loading control. ( n = 3 biologically independent experiments). (J) Protein expression of EGFR was examined by immunofluorescence staining in HaCaT cells treated with UBE2M. Scale bars, 10 μm. Representative images from one of three independent experiments are shown. ( n = 3 independent repeat experiments). (K–L) The interaction of UBE2M and EGFR was detected by CoIP. HaCaT cells were transfected with Flag-EGFR and HA-UBE2M for 48 h, followed by anti-HA (K) or anti-Flag (L) immunoprecipitation. Representative immunoblots from one of three independent experiments are shown ( n = 3 independent repeat experiments). (M) Endogenous UBE2M in HaCaT cells was shown to interact with EGFR through co-immunoprecipitation using UBE2M antibody. Mouse IgG served as a control. Representative immunoblots from one of three independent experiments are shown ( n = 3 independent repeat experiments). (N) Co-immunoprecipitation with EGFR antibody demonstrated the interaction between endogenous EGFR and UBE2M in HaCaT cells. Mouse IgG was used as a control. Representative immunoblots from one of three independent experiments are shown ( n = 3 independent repeat experiments). (O) In mouse skin, endogenous UBE2M interacted with EGFR through co-immunoprecipitation using UBE2M antibody. Mouse IgG acted as a control. Representative immunoblots from one of three independent experiments are shown ( n = 3 independent repeat experiments). (P) Co-immunoprecipitation with EGFR antibody revealed the interaction between endogenous EGFR and UBE2M in mouse skin. Mouse IgG was utilized as a control. Representative immunoblots from one of three independent experiments are shown ( n = 3 independent repeat experiments). (Q) The proliferation of HaCaT cells after overexpression of UBE2M and stimulation or non-stimulation of AG1478 was analyzed by the CCK-8 method. ( n = 3 biologically independent experiments). All data are expressed as mean ± SD. ns., not significant, ∗ p < 0.05, ∗∗ p < 0.01, ∗∗∗ p < 0.001, ∗∗∗∗ p < 0.0001 by unpaired Student’s t test (A, B, D, F, and Q) or by one-way ANOVA with post hoc Tukey (C, G, H, and I).

Article Snippet: Ube2m -knockdown mice , Gem Pharmatech , T003161.

Techniques: Expressing, Activity Assay, Modification, Over Expression, Western Blot, Control, Software, Knockdown, Transfection, Ubiquitin Proteomics, Immunoprecipitation, Immunohistochemical staining, Staining, Activation Assay, Immunofluorescence, CCK-8 Assay

UBE2M Enhances EGFR Neddylation (A) The NAE inhibitor MLN4924 inhibited the increase in EGFR expression mediated by UBE2M in the HaCaT cell line. The cells were administered MLN4924 (0.3 μM, 12 h) before harvesting. GAPDH served as the loading control and quantification for the indicated bands. ( n = 3 biologically independent experiments). (B) Western blot analysis of EGFR expression in HaCaT cells treated with UBE2M or UBE2M-C111S. GAPDH served as the loading control and quantification for the indicated bands. ( n = 3 biologically independent experiments). (C) EGFR associates with NEDD8. HA-NEDD8 and Flag-EGFR were transfected into HaCaT cells and treated with 0.3 μM MLN4924 for 12 h. Cell lysis was followed by immunoprecipitation with a Flag antibody, followed by immunoblotting with the indicated antibodies. Representative immunoblots from one of three independent experiments are shown ( n = 3 independent repeat experiments). (D) Endogenous EGFR is associated with NEDD8 via co-immunoprecipitation with the EGFR antibody. Mouse IgG was utilized as a control. Representative immunoblots from one of three independent experiments are shown ( n = 3 independent repeat experiments). (E) The neddylation of EGFR is increased upon UBE2M overexpression in HaCaT cells, detected by immunoprecipitation with a Flag antibody. Representative immunoblots from one of three independent experiments are shown ( n = 3 independent repeat experiments). (F) The neddylation of EGFR is reduced upon UBE2M knockdown in HaCaT cells, detected by immunoprecipitation with a Flag antibody. Representative immunoblots from one of three independent experiments are shown ( n = 3 independent repeat experiments). (G) In HaCaT cells, endogenous EGFR was shown to interact with NEDD8 through co-immunoprecipitation using EGFR antibody following IL-17 stimulation. Representative immunoblots from one of three independent experiments are shown ( n = 3 independent repeat experiments). (H) In HaCaT cells, endogenous NEDD8 was found to associate with EGFR through co-immunoprecipitation with NEDD8 antibody after IL-17 stimulation. Representative immunoblots from one of three independent experiments are shown ( n = 3 independent repeat experiments). (I) In Ker-CT cells, endogenous EGFR interacted with NEDD8 via co-immunoprecipitation using EGFR antibody following IL-17 stimulation. Representative immunoblots from one of three independent experiments are shown ( n = 3 independent repeat experiments). (J) Likewise, endogenous NEDD8 in Ker-CT cells was associated with EGFR through co-immunoprecipitation with NEDD8 antibody after IL-17 stimulation. Representative immunoblots from one of three independent experiments are shown ( n = 3 independent repeat experiments). (K) Endogenous EGFR in NHEK cells was found to associate with NEDD8 via co-immunoprecipitation using EGFR antibody after IL-17 treatment. Representative immunoblots from one of three independent experiments are shown ( n = 3 independent repeat experiments). (L) In NHEK cells, endogenous NEDD8 interacted with EGFR through co-immunoprecipitation using NEDD8 antibody after IL-17 stimulation. Representative immunoblots from one of three independent experiments are shown ( n = 3 independent repeat experiments). All data are expressed as mean ± SD. ∗ p < 0.05, ∗∗ p < 0.01 by one-way ANOVA with post hoc Tukey (A and B).

Journal: iScience

Article Title: UBE2M-mediated EGFR neddylation drives keratinocyte proliferation in psoriasis

doi: 10.1016/j.isci.2026.115784

Figure Lengend Snippet: UBE2M Enhances EGFR Neddylation (A) The NAE inhibitor MLN4924 inhibited the increase in EGFR expression mediated by UBE2M in the HaCaT cell line. The cells were administered MLN4924 (0.3 μM, 12 h) before harvesting. GAPDH served as the loading control and quantification for the indicated bands. ( n = 3 biologically independent experiments). (B) Western blot analysis of EGFR expression in HaCaT cells treated with UBE2M or UBE2M-C111S. GAPDH served as the loading control and quantification for the indicated bands. ( n = 3 biologically independent experiments). (C) EGFR associates with NEDD8. HA-NEDD8 and Flag-EGFR were transfected into HaCaT cells and treated with 0.3 μM MLN4924 for 12 h. Cell lysis was followed by immunoprecipitation with a Flag antibody, followed by immunoblotting with the indicated antibodies. Representative immunoblots from one of three independent experiments are shown ( n = 3 independent repeat experiments). (D) Endogenous EGFR is associated with NEDD8 via co-immunoprecipitation with the EGFR antibody. Mouse IgG was utilized as a control. Representative immunoblots from one of three independent experiments are shown ( n = 3 independent repeat experiments). (E) The neddylation of EGFR is increased upon UBE2M overexpression in HaCaT cells, detected by immunoprecipitation with a Flag antibody. Representative immunoblots from one of three independent experiments are shown ( n = 3 independent repeat experiments). (F) The neddylation of EGFR is reduced upon UBE2M knockdown in HaCaT cells, detected by immunoprecipitation with a Flag antibody. Representative immunoblots from one of three independent experiments are shown ( n = 3 independent repeat experiments). (G) In HaCaT cells, endogenous EGFR was shown to interact with NEDD8 through co-immunoprecipitation using EGFR antibody following IL-17 stimulation. Representative immunoblots from one of three independent experiments are shown ( n = 3 independent repeat experiments). (H) In HaCaT cells, endogenous NEDD8 was found to associate with EGFR through co-immunoprecipitation with NEDD8 antibody after IL-17 stimulation. Representative immunoblots from one of three independent experiments are shown ( n = 3 independent repeat experiments). (I) In Ker-CT cells, endogenous EGFR interacted with NEDD8 via co-immunoprecipitation using EGFR antibody following IL-17 stimulation. Representative immunoblots from one of three independent experiments are shown ( n = 3 independent repeat experiments). (J) Likewise, endogenous NEDD8 in Ker-CT cells was associated with EGFR through co-immunoprecipitation with NEDD8 antibody after IL-17 stimulation. Representative immunoblots from one of three independent experiments are shown ( n = 3 independent repeat experiments). (K) Endogenous EGFR in NHEK cells was found to associate with NEDD8 via co-immunoprecipitation using EGFR antibody after IL-17 treatment. Representative immunoblots from one of three independent experiments are shown ( n = 3 independent repeat experiments). (L) In NHEK cells, endogenous NEDD8 interacted with EGFR through co-immunoprecipitation using NEDD8 antibody after IL-17 stimulation. Representative immunoblots from one of three independent experiments are shown ( n = 3 independent repeat experiments). All data are expressed as mean ± SD. ∗ p < 0.05, ∗∗ p < 0.01 by one-way ANOVA with post hoc Tukey (A and B).

Article Snippet: Ube2m -knockdown mice , Gem Pharmatech , T003161.

Techniques: Expressing, Control, Western Blot, Transfection, Lysis, Immunoprecipitation, Over Expression, Knockdown

CUL4A-RBX1 and CUL4B-RBX1 act as E3 ligases for EGFR neddylation (A and B) The interaction of RBX1 and EGFR was detected by CoIP. HaCaT cells were transfected with Flag-EGFR and HA-RBX1 for 48 h, followed by anti-Flag (A) or anti-HA (B) immunoprecipitation. Representative immunoblots from one of three independent experiments are shown ( n = 3 independent repeat experiments). (C) The interaction of EGFR and NEDD8 with and without RBX1 knockdown using siRNA. Anti-Flag immunoprecipitation was employed as indicated. Representative immunoblots from one of three independent experiments are shown ( n = 3 independent repeat experiments). (D) The neddylation of EGFR under various cullins knockdown conditions was detected by immunoprecipitation with a Flag antibody. Representative immunoblots from one of three independent experiments are shown ( n = 3 independent repeat experiments). (E and F) The interaction of EGFR and CUL4A was detected by CoIP. HaCaT cells were transfected with Flag-EGFR and MYC-CUL4A for 48 h, followed by anti-Flag (E) or anti-MYC (F) immunoprecipitation. Representative immunoblots from one of three independent experiments are shown ( n = 3 independent repeat experiments). (G and H) The interaction of EGFR and CUL4B was detected by CoIP. HaCaT cells were transfected with Flag-EGFR and HA-CUL4B for 48 h, followed by anti-Flag (G) or anti-HA (H) immunoprecipitation. Representative immunoblots from one of three independent experiments are shown ( n = 3 independent repeat experiments). (I and J) The physical interaction of NEDD8 and Flag-EGFR in HaCaT cells with and without CUL4A (I) or CUL4B (J) overexpression. Cell lysates were immunoprecipitated using Flag antibodies. Representative immunoblots from one of three independent experiments are shown ( n = 3 independent repeat experiments). (K) The physical interaction of CUL4A and CUL4B with endogenous EGFR in HaCaT cells with and without UBE2M overexpression. Cell lysates were immunoprecipitated with IgG or EGFR antibodies. Representative immunoblots from one of three independent experiments are shown ( n = 3 independent repeat experiments). (L) A diagrammatic summary of how UBE2M promotes the progression of psoriasis by enhancing EGFR neddylation and stability.

Journal: iScience

Article Title: UBE2M-mediated EGFR neddylation drives keratinocyte proliferation in psoriasis

doi: 10.1016/j.isci.2026.115784

Figure Lengend Snippet: CUL4A-RBX1 and CUL4B-RBX1 act as E3 ligases for EGFR neddylation (A and B) The interaction of RBX1 and EGFR was detected by CoIP. HaCaT cells were transfected with Flag-EGFR and HA-RBX1 for 48 h, followed by anti-Flag (A) or anti-HA (B) immunoprecipitation. Representative immunoblots from one of three independent experiments are shown ( n = 3 independent repeat experiments). (C) The interaction of EGFR and NEDD8 with and without RBX1 knockdown using siRNA. Anti-Flag immunoprecipitation was employed as indicated. Representative immunoblots from one of three independent experiments are shown ( n = 3 independent repeat experiments). (D) The neddylation of EGFR under various cullins knockdown conditions was detected by immunoprecipitation with a Flag antibody. Representative immunoblots from one of three independent experiments are shown ( n = 3 independent repeat experiments). (E and F) The interaction of EGFR and CUL4A was detected by CoIP. HaCaT cells were transfected with Flag-EGFR and MYC-CUL4A for 48 h, followed by anti-Flag (E) or anti-MYC (F) immunoprecipitation. Representative immunoblots from one of three independent experiments are shown ( n = 3 independent repeat experiments). (G and H) The interaction of EGFR and CUL4B was detected by CoIP. HaCaT cells were transfected with Flag-EGFR and HA-CUL4B for 48 h, followed by anti-Flag (G) or anti-HA (H) immunoprecipitation. Representative immunoblots from one of three independent experiments are shown ( n = 3 independent repeat experiments). (I and J) The physical interaction of NEDD8 and Flag-EGFR in HaCaT cells with and without CUL4A (I) or CUL4B (J) overexpression. Cell lysates were immunoprecipitated using Flag antibodies. Representative immunoblots from one of three independent experiments are shown ( n = 3 independent repeat experiments). (K) The physical interaction of CUL4A and CUL4B with endogenous EGFR in HaCaT cells with and without UBE2M overexpression. Cell lysates were immunoprecipitated with IgG or EGFR antibodies. Representative immunoblots from one of three independent experiments are shown ( n = 3 independent repeat experiments). (L) A diagrammatic summary of how UBE2M promotes the progression of psoriasis by enhancing EGFR neddylation and stability.

Article Snippet: Ube2m -knockdown mice , Gem Pharmatech , T003161.

Techniques: Transfection, Immunoprecipitation, Western Blot, Knockdown, Over Expression